These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30131168)

  • 41. External validity, generalizability, and knowledge utilization.
    Ferguson L
    J Nurs Scholarsh; 2004; 36(1):16-22. PubMed ID: 15098414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Real-world Data for Clinical Evidence Generation in Oncology.
    Khozin S; Blumenthal GM; Pazdur R
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Opportunities and Challenges of Pragmatic Randomized Trials Using a Specialized Software: CloudTrials Project.
    Fosser SM; Kamozin A; McDonald EG; Tamblyn R; Lee TC
    Stud Health Technol Inform; 2019 Aug; 264():1544-1545. PubMed ID: 31438223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-world experiences with generating real-world evidence: Case Studies from PCORI's pragmatic clinical Studies program.
    Neuman MD; Kappelman MD; Israel E; Ellenberg SS; Girman C; Robb J; Rabinowitz A; Trontell A
    Contemp Clin Trials; 2020 Nov; 98():106171. PubMed ID: 33038503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The importance of decision intent within descriptions of pragmatic trials.
    Nicholls SG; Zwarenstein M; Hey SP; Giraudeau B; Campbell MK; Taljaard M
    J Clin Epidemiol; 2020 Sep; 125():30-37. PubMed ID: 32422248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pragmatic study designs for older adults with cancer: Report from the U13 conference.
    Nipp RD; Yao NA; Lowenstein LM; Buckner JC; Parker IR; Gajra A; Morrison VA; Dale W; Ballman KV
    J Geriatr Oncol; 2016 Jul; 7(4):234-41. PubMed ID: 27197914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pragmatic randomized trials in drug development pose new ethical questions: a systematic review.
    Kalkman S; van Thiel GJ; Grobbee DE; van Delden JJ
    Drug Discov Today; 2015 Jul; 20(7):856-62. PubMed ID: 25794600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences.
    Oude Rengerink K; Kalkman S; Collier S; Ciaglia A; Worsley SD; Lightbourne A; Eckert L; Groenwold RHH; Grobbee DE; Irving EA;
    J Clin Epidemiol; 2017 Sep; 89():173-180. PubMed ID: 28502808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methodological considerations with secondary analyses.
    Pollack CD
    Outcomes Manag Nurs Pract; 1999; 3(4):147-52. PubMed ID: 10876539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conducting rapid, relevant research: lessons learned from the My Own Health Report project.
    Glasgow RE; Kessler RS; Ory MG; Roby D; Gorin SS; Krist A
    Am J Prev Med; 2014 Aug; 47(2):212-9. PubMed ID: 24953520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How study designs influence comparative effectiveness outcomes: the case of oral versus long-acting injectable antipsychotic treatments for schizophrenia.
    Alphs L; Schooler N; Lauriello J
    Schizophr Res; 2014 Jul; 156(2-3):228-32. PubMed ID: 24842538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pragmatic (trial) informatics: a perspective from the NIH Health Care Systems Research Collaboratory.
    Richesson RL; Green BB; Laws R; Puro J; Kahn MG; Bauck A; Smerek M; Van Eaton EG; Zozus M; Hammond WE; Stephens KA; Simon GE
    J Am Med Inform Assoc; 2017 Sep; 24(5):996-1001. PubMed ID: 28340241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pragmatic Clinical Trials in CKD: Opportunities and Challenges.
    de Boer IH; Kovesdy CP; Navaneethan SD; Peralta CA; Tuot DS; Vazquez MA; Crews DC;
    J Am Soc Nephrol; 2016 Oct; 27(10):2948-2954. PubMed ID: 27283497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Explanatory trials versus pragmatic trials.
    Sedgwick P
    BMJ; 2014 Nov; 349():g6694. PubMed ID: 25395503
    [No Abstract]   [Full Text] [Related]  

  • 55. Publishing pragmatic trials.
    Pickler RH; Kearney MH
    Nurs Outlook; 2018 Sep; 66(5):464-469. PubMed ID: 29903502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incentives and payments in pragmatic clinical trials: Scientific, ethical, and policy considerations.
    Garland A; Weinfurt K; Sugarman J
    Clin Trials; 2021 Dec; 18(6):699-705. PubMed ID: 34766524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients and investigators prefer measures of absolute risk in subgroups for pragmatic randomized trials.
    Murray EJ; Caniglia EC; Swanson SA; Hernández-Díaz S; Hernán MA
    J Clin Epidemiol; 2018 Nov; 103():10-21. PubMed ID: 29966732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials.
    Sajobi TT; Li G; Awosoga O; Wang M; Menon BK; Hill MD; Thabane L
    Syst Rev; 2018 Jan; 7(1):19. PubMed ID: 29370830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pragmatic patient engagement in designing pragmatic oncology clinical trials.
    Davies-Teye BB; Medeiros M; Chauhan C; Baquet CR; Mullins CD
    Future Oncol; 2021 Oct; 17(28):3691-3704. PubMed ID: 34337970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Five analytic challenges in working with electronic health records data to support clinical trials with some solutions.
    Goldstein BA
    Clin Trials; 2020 Aug; 17(4):370-376. PubMed ID: 32589046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.